Sirviö J, Soininen H S, Kutvonen R, Hyttinen J M, Helkala E L, Riekkinen P J
Department of Neurology, University of Kuopio, Finland.
J Neurol Sci. 1987 Nov;81(2-3):273-9. doi: 10.1016/0022-510x(87)90102-x.
In this study we investigated acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activities and the molecular forms of these enzymes in the cerebrospinal fluid (CSF) of non-demented and demented Parkinsonian patients and in controls. The ratio of AChE to BChE activity was lower in the CSF of demented patients than in non-demented patients, although AChE and BChE activities and the molecular forms of AChE and BChE were the same in the different groups of patients. AChE activity in CSF did not vary according to the severity or duration of dementia associated with Parkinson's disease or with the disability stage of Parkinson's disease. BChE activity in CSF correlated with these clinical parameters, and patients with cerebral atrophy had higher BChE activity in CSF than those patients without atrophy. These alterations in the BChE activity of CSF may be related to gliosis which occurs in the degenerating brain tissue.
在本研究中,我们调查了非痴呆和痴呆帕金森病患者以及对照组脑脊液(CSF)中乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)的活性及其分子形式。痴呆患者脑脊液中AChE与BChE活性之比低于非痴呆患者,尽管不同组患者的AChE和BChE活性以及AChE和BChE的分子形式相同。脑脊液中的AChE活性并不随帕金森病相关痴呆的严重程度或持续时间以及帕金森病的残疾阶段而变化。脑脊液中的BChE活性与这些临床参数相关,脑萎缩患者脑脊液中的BChE活性高于无萎缩患者。脑脊液中BChE活性的这些改变可能与退变脑组织中发生的胶质增生有关。